Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Glycinebetaine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | APEX1 | P27695 | 1/20 | 0.50 |
| ▸ | SLC22A16 | Q86VW1 | 1/20 | 0.46 |
| ▸ | CPT2 | P23786 | 1/20 | 0.42 |
| ▸ | CPT1A | P50416 | 1/20 | 0.42 |
| ▸ | BBOX1 | O75936 | 6/20 | 0.40 |
| ▸ | CA4 | P22748 | 2/20 | 0.39 |
| ▸ | FFAR3 | O14843 | 2/20 | 0.38 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.38 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.38 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.38 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | HRH1 | P35367 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | CRAT | P43155 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glycinebetaine SCHEMBL7739 | 1.00 | — | — | |
| Glycinebetaine SCHEMBL8678519 | 1.00 | TSHR (0.53) | TSHRALDH1A1LMNAAPEX1SLC22A16 | |
| Betaine SCHEMBL31467313 | 1.00 | — | — | |
| Glycinebetaine SCHEMBL4900209 | 1.00 | — | — | |
| Glycinebetaine SCHEMBL11109389 | 0.97 | — | — | |
| Glycinebetaine SCHEMBL4255367 | 0.97 | — | — | |
| Glycinebetaine SCHEMBL8388807 | 0.97 | — | — | |
| Glycinebetaine SCHEMBL4457941 | 0.97 | TSHR (0.50) | TSHRALDH1A1LMNAAPEX1SLC22A16 | |
| Glycinebetaine SCHEMBL20703289 | 0.97 | — | — | |
| Glycinebetaine SCHEMBL61181 | 0.97 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024149047-A1 | CRYOPRESERVATION SOLUTION BASED ON LIQUID-LIQUID CONDENSED PHASE, PREPARATION METHOD THEREFOR AND USE THEREOF | 中国科学院化学研究所 | 2024-07-18 | — | — | WO | disclosed |
| EP-3537876-B1 | ANTHELMINTHIC COMPOSITION | AGRESEARCH LTD (NZ) | 2024-04-10 | — | — | EP | disclosed |
| WO-2024058984-A2 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING INSULIN-ASSOCIATED DISEASES | MarvelBiome, Inc. (US) | 2024-03-21 | — | — | WO | disclosed |
| CN-117202888-A | Multiphase liquid compositions with improved deposition of active ingredients | 法国特种经营公司 | 2023-12-08 | — | — | CN | disclosed |
| CN-113950374-B | Arrangement of reagents in an analysis device | 维迪亚控股有限公司 | 2023-07-28 | — | — | CN | disclosed |
| EP-4190551-A1 | METHOD FOR USING A NANOMESH MULTILAYER BODY | Mitsubishi Chemical Corporation (JP) | 2023-06-07 | — | — | EP | disclosed |
| US-20220143597-A1 | DISPOSITION OF REAGENTS IN ASSAY DEVICE | VIDYA HOLDINGS LTD (GB) | 2022-05-12 | — | — | US | disclosed |
| US-20220146505-A1 | DISPOSITION OF REAGENTS IN ASSAY DEVICE | VIDYA HOLDINGS LTD (GB) | 2022-05-12 | — | — | US | disclosed |
| US-20220055340-A1 | NANOMESH MULTILAYER BODY, METHOD FOR PRODUCING CONDUCTIVE CIRCUIT AND NANOMESH BONDING KIT | MITSUBISHI CHEMICAL CORPORATION (JP) | 2022-02-24 | — | — | US | disclosed |
| CN-113950373-A | Arrangement of reagents in an analytical device | 维迪亚控股有限公司 | 2022-01-18 | — | — | CN | disclosed |
| EP-0824345-A4 | S-ADENOSYL METHIONINE REGULATION OF METABOLIC PATHWAYS AND ITS USE IN DIAGNOSIS AND THERAPY | ORIDIGM CORP (US) | 1999-08-25 | — | — | EP | disclosed |
| EP-0828853-A4 | IMPROVED METHOD FOR NUCLEOTIDE SEQUENCE AMPLIFICATION | GENZYME CORP (US) | 1998-05-13 | — | — | EP | disclosed |
| EP-0828853-A1 | IMPROVED METHOD FOR NUCLEOTIDE SEQUENCE AMPLIFICATION | GENZYME CORPORATION (US) | 1998-03-18 | — | — | EP | disclosed |
| EP-0824345-A1 | S-ADENOSYL METHIONINE REGULATION OF METABOLIC PATHWAYS AND ITS USE IN DIAGNOSIS AND THERAPY | ORIDIGM CORPORATION (US) | 1998-02-25 | — | — | EP | disclosed |
| EP-0742838-A1 | METHODS FOR THE ELIMINATION OF DNA SEQUENCING ARTIFACTS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1996-11-20 | — | — | EP | disclosed |
| WO-1996033703-A2 | S-ADENOSYL METHIONINE REGULATION OF METABOLIC PATHWAYS AND ITS USE IN DIAGNOSIS AND THERAPY | ORIDIGM CORPORATION (US) | 1996-10-31 | — | — | WO | disclosed |
| US-5545539-A | PLYMERASE CHAIN REACTION, N,N,N-TRIMETHYLGLYCINE USED AS AMPLIFIER AGENT, TARGET TRINUCLEOTIDE REPEAT SEQUENCE, INDICATIVE OR HUNTINGTON'S DISEASE | GENZYME CORPORATION (US) | 1996-08-13 | — | — | US | disclosed |
| WO-1996012041-A1 | IMPROVED METHOD FOR NUCLEOTIDE SEQUENCE AMPLIFICATION | GENZYME CORPORATION (US) | 1996-04-25 | — | — | WO | disclosed |
| WO-1995020682-A1 | METHODS FOR THE ELIMINATION OF DNA SEQUENCING ARTIFACTS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1995-08-03 | — | — | WO | disclosed |
| US-4212966-A | AGITATING MELT WITH SURFACTANT TO FORM DISPERSION | NATIONAL DISTILLERS & CHEMICAL CORPORATION (US) | 1980-07-15 | — | — | US | disclosed |